Monod Bio Raises $25M To Quickly Diagnose Diseases

Much of disease detection goes like this: A physician directs a patient to get their labs done. Patient goes to get their blood drawn. After days or weeks, lab results arrive at the doctor’s office, when diagnosis and real treatment begins.

But what if doctors could detect a disease at their office? Seattle-based biotech startup Monod Bio announced on Monday it raised $25 million in seed funding led by Matrix Capital to help them accomplish that goal.